TABLE 2.
Formation of HSV infectious centers and plaques on susceptible BHK(TK−) cells, resistant US11cl19.3/pcDNA cells, and HVEM-expressing US11cl19.3/BEC cells
| Test cells | Input PFUa | HSV-1(F)
|
HSV-2(G)
|
||
|---|---|---|---|---|---|
| Infectious centersb | Test cell plaquesc | Infectious centers | Test cell plaques | ||
| BHK(TK−) | 5 × 104 | TNTCd | TNTC | TNTC | TNTC |
| 5 × 103 | 128 | 232 | 84 | 80 | |
| 5 × 102 | 14 | 22 | 16 | 28 | |
| US11cl19.3/pcDNA | 5 × 107 | TNTC | 0 | TNTC | 1 |
| 5 × 106 | 98 | 0 | 56 | 0 | |
| 5 × 105 | 6 | 0 | 2 | 0 | |
| US11cl19.3/BEC | 5 × 107 | TNTC | 32 | TNTC | 76 |
| 5 × 106 | 58 | 2 | 36 | 10 | |
| 5 × 105 | 6 | 0 | 0 | 0 | |
| 5 × 104 | 0 | 0 | 0 | 0 | |
Determined by titration of virus stock on Vero cells.
Number of plaques obtained following seeding of infected test cells onto a Vero cell monolayer in the presence of neutralizing antibody.
Number of plaques observed on the infected test cell monolayer. Plaques are defined as two or more adjacent infected cells. Macroscopic plaques were rarely formed on US11cl19.3 cells.
TNTC, too numerous to count.